|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2005-10-3
|
|
pubmed:abstractText |
We tested the hypothesis that the combination of trimetrexate (TMTX) and capecitabine (CAP) would be active in patients with previously treated metastatic colorectal cancer (CRC). Because the optimum dose of this combination was unknown, we used a phase I/II design.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1537-453X
|
|
pubmed:author |
pubmed-author:EarleMartinM,
pubmed-author:EvansTerryT,
pubmed-author:FerriWilliamW,
pubmed-author:FriedlandDavidD,
pubmed-author:JacobsSamuel ASA,
pubmed-author:MatinKhalidK,
pubmed-author:PinkertonRichardR,
pubmed-author:RamanathanRamesh KRK,
pubmed-author:RichardsThomasT,
pubmed-author:TroetschelMonicaM,
pubmed-author:VolkinRobertR,
pubmed-author:WieandSamuelS,
pubmed-author:WongMichael KMK
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
439-44
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16199980-Adult,
pubmed-meshheading:16199980-Aged,
pubmed-meshheading:16199980-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16199980-Colorectal Neoplasms,
pubmed-meshheading:16199980-Deoxycytidine,
pubmed-meshheading:16199980-Female,
pubmed-meshheading:16199980-Fluorouracil,
pubmed-meshheading:16199980-Humans,
pubmed-meshheading:16199980-Male,
pubmed-meshheading:16199980-Middle Aged,
pubmed-meshheading:16199980-Neoplasm Staging,
pubmed-meshheading:16199980-Trimetrexate
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer.
|
|
pubmed:affiliation |
Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
